{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05433090",
            "orgStudyIdInfo": {
                "id": "UOCPC22039"
            },
            "organization": {
                "fullName": "University of Rochester",
                "class": "OTHER"
            },
            "briefTitle": "An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies",
            "officialTitle": "An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies",
            "acronym": "APP SICP",
            "therapeuticArea": [
                "Other"
            ],
            "study": "an-inpatient-advance-care-planning-intervention-for-older-patients-with-hematologic-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-21",
            "studyFirstSubmitQcDate": "2022-06-21",
            "studyFirstPostDateStruct": {
                "date": "2022-06-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Kah Poh Loh",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Rochester"
            },
            "leadSponsor": {
                "name": "University of Rochester",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies",
            "detailedDescription": "Older adults with hematologic malignancies receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness conversations for patients with hematologic malignancies, leading to less aggressive healthcare utilization at the end of life. This pilot aims to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies."
        },
        "conditionsModule": {
            "conditions": [
                "Hematologic Malignancies"
            ],
            "keywords": [
                "Advance Care Planning Intervention",
                "Serious Illness Conversation",
                "Hematologic Malignancies"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "The intervention used in this study is an inpatient advance care planning intervention. We will adapt the Serious Illness Care Program, an evidence-based intervention that promotes serious illness conversation between patients and clinicians, to be used by advance practice providers and hematology/oncology fellow physicians in the inpatient setting.",
                "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Experimental",
                    "type": "EXPERIMENTAL",
                    "description": "Patients will participate in an inpatient advance care planning intervention.",
                    "interventionNames": [
                        "Behavioral: Inpatient serious illness care program"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Inpatient serious illness care program",
                    "description": "Inpatient advance care planning intervention that will be delivered by advanced care practitioners or hematology/oncology fellow physicians. The intervention will be an adapted version of the serious illness care program.",
                    "armGroupLabels": [
                        "Experimental"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Completion of advance directives",
                    "description": "Data on completion of advance directives will be collected via the electronic medical record. This will include explicit statement of the patient's medical preferences for end of life care in a note, scanned medical order for life sustaining treatment (MOLST) form that was completed with their clinician, and/or scanned healthcare proxy form that was completed with their clinician. This will be expressed as a percentage.",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "End of life quality indicators",
                    "description": "End of life quality indicators will be extracted from the electronic medical record. These metrics will include hospice enrollment, palliative care referral, chemotherapy administration within the last 2 weeks of life, emergency department visits in the last 30 days of life, intensive care unit admissions in the last 30 days of life, hospitalizations in the last 30 days of life, use of life-sustaining treatments in the last 30 days of life, transfusions in the last 7 days of life, and place of death. These will be expressed as percentages.",
                    "timeFrame": "Up to 5 years following their participation in the study or death"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226560 years\n* A diagnosis of hematologic malignancy \\[including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment\\]\n* Able to provide informed consent\n* Being managed in the inpatient setting\n* English-speaking\n\nExclusion Criteria:\n\n\u2022 None",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "60 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kah Poh Loh",
                    "role": "CONTACT",
                    "phone": "585-275-4401",
                    "email": "kahpoh_loh@urmc.rochester.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kah Poh Loh",
                    "affiliation": "University of Rochester",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "New York",
                    "zip": "14642",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kah Poh Loh",
                            "role": "CONTACT",
                            "phone": "585-275-4401",
                            "email": "Kahpoh_Loh@URMC.Rochester.edu"
                        },
                        {
                            "name": "Marissa LoCastro",
                            "role": "CONTACT",
                            "phone": "585-275-4391",
                            "email": "Marissa_LoCastro@urmc.rochester.edu"
                        },
                        {
                            "name": "Kah Poh Loh",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Marissa LoCastro",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.15478,
                        "lon": -77.61556
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34525170",
                    "type": "BACKGROUND",
                    "citation": "LoCastro M, Baran AM, Liesveld JL, Huselton E, Becker MW, O'Dwyer KM, Aljitawi OS, Baumgart M, Snyder E, Kluger B, Loh KP, Mendler JH. Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes. Blood Adv. 2021 Dec 28;5(24):5554-5564. doi: 10.1182/bloodadvances.2021004775."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "A final study protocol including a description of the study participants, measurements, data, and analyses will be made publicly available before the publication date of the study findings. This will be available through the University of Rochester Cancer Center Community Oncology Research Program Research Base Protocol and Data Sharing Committee. The database will be de-identified prior to becoming publicly available. Published manuscripts will be available in portable document format.",
            "infoTypes": [
                "STUDY_PROTOCOL"
            ],
            "timeFrame": "Data will be available for 7 years (starting from accrual of first participant)"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000019337",
                    "term": "Hematologic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21314",
                    "name": "Hematologic Neoplasms",
                    "asFound": "Hematologic Malignancies",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}